38.88
3.88%
-1.57
Dopo l'orario di chiusura:
38.88
Precedente Chiudi:
$40.45
Aprire:
$40.07
Volume 24 ore:
144.27K
Relative Volume:
1.28
Capitalizzazione di mercato:
$582.31M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-15.61%
1M Prestazione:
+3.96%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Nome
Tectonic Therapeutic Inc
Settore
Industria
Telefono
(339) 666-3320
Indirizzo
490 ARSENAL WAY, WATERTOWN
Confronta TECX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
TECX | 38.88 | 582.31M | 0 | 0 | 0 | 0.00 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Tectonic Therapeutic Inc Borsa (TECX) Ultime notizie
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $69.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High Following Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Reports Q3 2024 Results - Yahoo Finance
BML Capital Management LLC Sells 254,295 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain - Simply Wall St
Tectonic Therapeutic price target raised to $79 from $55 at Wells Fargo - TipRanks
Tectonic Therapeutic Announces Positive Phase 1a Results in - GlobeNewswire
Tectonic's TX45 Shows Strong Phase 1 Results: 42% Renal Flow Boost, 20-Day Half-Life | TECX Stock News - StockTitan
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.38 - Defense World
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $68.50 - Defense World
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives $23.83 Average PT from Analysts - Defense World
Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 12-Month HighStill a Buy? - MarketBeat
Mineralys Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High – Still a Buy? - Defense World
Reviewing Tectonic Therapeutic (NASDAQ:TECX) and Mesoblast (NASDAQ:MESO) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year HighTime to Buy? - MarketBeat
X4 Pharmaceuticals (NASDAQ:XFOR) vs. Tectonic Therapeutic (NASDAQ:TECX) Critical Analysis - Defense World
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High on Insider Buying Activity - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High Following Insider Buying Activity - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Director Acquires $10,077,000.00 in Stock - MarketBeat
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock By Investing.com - Investing.com Australia
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock - Investing.com India
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - The Manila Times
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024 - The Bakersfield Californian
Tectonic Therapeutic: Interesting CV Disease Drug Developer (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Short Interest in Tectonic Therapeutic (NASDAQ:TECX) Increases By 258.0% - MarketBeat
Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 4.5%Here's Why - MarketBeat
Vida Ventures Advisors LLC Takes $31.17 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome - Yahoo Finance
89,029 Shares in Tectonic Therapeutic (NASDAQ:TECX) Acquired by Renaissance Technologies LLC - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Hits New 52-Week HighHere's Why - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading 5.8% Higher - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 7% - MarketBeat
Navigating Uncertainty: Tectonic Therapeutic’s Clinical Data Volatility and Its Impact on Business Stability - TipRanks
Insider Activity Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com Nigeria
Tectonic Therapeutic director buys shares worth over $1.4 million By Investing.com - Investing.com South Africa
Timothy A. Springer Acquires 50,000 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - Defense World
Tectonic Therapeutic director buys shares worth over $1.4 million - Investing.com India
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Update - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc Azioni (TECX) Dati Finanziari
Non sono disponibili dati finanziari per Tectonic Therapeutic Inc (TECX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):